Ummmm….maybe not. At least, that’s the stance of the FDA, and of pretty much anyone with common sense. But – not all pharma sales reps have common sense.
Note to pharma clients: worth including this as a case study in your compliance training for sales reps.
(hat tip for link: Larry Lynam)
Get the Impactiviti overview